Short answer · Medically reviewed summary · Last updated: 2026-04-06
Scleroderma, also known as systemic sclerosis, is a complex autoimmune condition characterized by the hardening and tightening of the skin and connective tissues, and it is frequently referred to by several clinical synonyms depending on the specific subtype and historical context. Common Synonyms and Classifications In modern medical literature, Scleroderma is most commonly divided into two main categories: localized scleroderma (often called morphea) and systemic sclerosis (SSc). While the terms are sometimes used interchangeably by patients, medical professionals distinguish them based on whether internal organs are involved.
2 people with Scleroderma have shared their first-person experience on this question at DiseaseMaps.
Scleroderma, also known as systemic sclerosis, is a complex autoimmune condition characterized by the hardening and tightening of the skin and connective tissues, and it is frequently referred to by several clinical synonyms depending on the specific subtype and historical context.
In modern medical literature, Scleroderma is most commonly divided into two main categories: localized scleroderma (often called morphea) and systemic sclerosis (SSc). While the terms are sometimes used interchangeably by patients, medical professionals distinguish them based on whether internal organs are involved. Historical names that may appear in older clinical records include "dermatosclerosis," "sclerema," and "progressive systemic sclerosis." In some international settings, you may encounter the term "CREST syndrome," which is a historical acronym describing a specific, limited subset of Scleroderma characterized by Calcinosis, Raynaud’s phenomenon, Esophageal dysmotility, Sclerodactyly, and Telangiectasia.
The existence of multiple names for Scleroderma stems from its diverse clinical presentation. Because the disease can manifest as a skin-only condition or a systemic, multi-organ process, researchers have historically developed different names to reflect these variations. Furthermore, as our understanding of the pathophysiology—specifically the roles of fibrosis and autoimmunity—has evolved, medical classification systems have shifted to prioritize the term "systemic sclerosis" to accurately capture the systemic nature of the disease. In the ICD-10 and ICD-11 coding systems, you will most often see the condition indexed under systemic sclerosis, while Orphanet (ORPHA:819) and OMIM (181750) provide standardized reference points to ensure consistency for patients and clinicians worldwide.
Today, the medical community prefers "systemic sclerosis" when referring to the condition affecting internal organs, while "localized scleroderma" is the accepted term for skin-restricted disease. Understanding these synonyms is vital for patients navigating medical records or searching for Scleroderma research, as older literature or international databases may use these terms interchangeably. Recognizing these variations helps ensure that individuals within our Scleroderma community can effectively communicate with their specialists and access the most relevant clinical data.
Disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment. Always consult with your rheumatologist or primary care physician regarding your specific health concerns.